Nyxoah to Participate in Upcoming Investor Conferences
Mont-Saint-Guibert, Belgium, Sept. 5 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in two upcoming investor conferences in New York City. Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver [...]








